Skip Ribbon Commands
Skip to main content

Dr Huang Mingjie

Dr Huang Mingjie from National Heart Centre Singapore NHCS

Dr Huang Mingjie

MBBS, MRCSEd, FRCSEd (CTh), FAMS​

Associate Consultant

Specialty: Cardiothoracic Surgery

Sub-specialties: Thoracic Surgery

Clinical Appointments

  • Associate Consultant Department of Cardiothoracic Surgery National Heart Centre SingaporeNational Heart Centre Singapore
  • Thoracic Surgeon SingHealth Duke-NUS Lung Centre
  • Associate Consultant Thoracic Surgery Sengkang General HospitalSengkang General Hospital

Academic Appointments

  • Adjunct Research Fellow SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme

Profile

Dr Huang Mingjie is an Associate Consultant from the Department of Cardiothoracic Surgery at National Heart Centre Singapore. He graduated from the National University of Singapore in 2012. He completed his training in cardiothoracic surgery at the National Heart Centre Singapore where he was awarded the annual RiSE Award(Residency in Singhealth Excels Award) multiple times for having exceptional clinical and academic performance in the top 5% of each Residency cohort. He also topped the national annual in-training examination in 2019 and 2021. He was admitted as a Fellow of the Royal College of Surgeons (Edinburgh) in 2021. He also led as Singhealth Chief Resident of Cardiothoracic Surgery from 2019 to 2021 and served in the national MOH Holdings Healthcare Leadership College’s 7th Singapore Chief Residency Programme. He currently serves as an invited alumni council member in the Singapore Chief Residency Programme.

In addition to his clinical duties, Dr Huang is also actively involved in research, medical education and quality improvement. He is an adjunct research fellow with Singhealth Duke-NUS Cardiovascular Sciences Academic Clinical programme. He was appointed Singhealth Associate in Education based on positive feedback from junior doctors he mentored. Further, he also serves as Clinical Teacher of Lee Kong Chian School of Medicine. Dr Huang also serves on the Singhealth Joy at Work Taskforce, a committee that works with senior management to effectively deliver patient care and optimise working conditions for junior doctors. He is team leader of two successful quality improvement projects – “Prescribing practices and Medication Wastage in Singapore”, which came in 1st place in the 7th Singapore Chief Residency Programme, as well as “Reducing the number of Chest X rays done after removal of intrapleural drains in Cardiac Surgery patients”, which was featured at the Singhealth Duke-NUS Quality and Innovation Day.

Education

  • FAMS, 2022
  • FRCSEd (CTh), 2022
  • MRCSEd, 2017
  • MBBS, National University of Singapore, 2012

Professional Appointments and Committee Memberships

  • ​Associate Consultant, Department of Cardiothoracic Surgery, National Heart Centre Singapore, March 2022 – Present
  • Singapore Chief Residency Programme Alumni Council Member, MOH Holdings Healthcare Leadership College, 13/10/21 – Present
  • MOH Holdings Healthcare Leadership College - Chief Resident (7th Singapore Chief Residency Programme), 24/7/19 – 6/1/21
  • Singhealth Chief Resident, 1/6/19 – 30/6/21
  • Committee Member, Singhealth Joy at Work Taskforce, 26/7/21 – Present
  • Content Expert, Clinical Teacher and Clinical Practice Facilitator, 1/3/22 – 30/6/23
  • Clinical Teacher, Lee Kong Chian School of Medicine, 1/7/21 – 30/6/23
  • Singhealth Associate in Education, 7/9/20 – Present
  • Adjunct Research Fellow, Singhealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme, 30/7/19 – 31/7/24
  • Surgery in General Residency MRCS Part B Preparatory Course Faculty Member/Examiner 8 – 15/1/22
  • Team leader, Quality Improvement team – Prescribing practices and Medication wastage in Singapore, 1/2/20 – 6/1/21
  • Team leader, Quality Improvement team – Reducing the number of chest x rays done after intrapleural drain removal in Cardiac Surgery from 100% to 50% over 5 months, 5/7/21 – 19/11/21

Awards

Clinical and Academic

  • RiSE(Residency in Singhealth Excels) Award AY2020/2021 – Outstanding Resident Award – Top 5% of each Residency cohort who have done exceptionally well in their clinical and academic avenues of medical education. 2021.
  • RiSE(Residency in Singhealth Excels) Award AY2019/2020 – Outstanding Resident Award – Top 5% of each Residency cohort who have done exceptionally well in their clinical and academic avenues of medical education. 2020.
  • RiSE Award Residency in Singhealth Excels! Award for outstanding performance in Academic and Clinical learning. 2013.
  • Residency annual in-training examination (Thoracic Surgery Director’s Association) – National Top Scorer 2021
  • Residency annual in-training examination (Thoracic Surgery Director’s Association) – National Top Scorer 2019
Quality Improvement and Research
  • Best Project (7th Singapore Chief Residency Programme) – Quality Improvement, Prescribing practices and Medication wastage in Singapore. 6.1.22
  • Nominated Speaker (Singhealth Duke-NUS Quality and Innovation Day 2022) – Quality Improvement, Reducing the number of chest x rays done after intrapleural drain removal in Cardiac Surgery patients. 11.3.22.
  • Oral presentation – 2nd place at 28th Annual meeting of Association of Thoracic and Cardiovascular Surgeons of Asia. Long-term Prognosis in Patients with End-Stage Renal Disease after Coronary Artery Bypass Grafting. 2018.
  • Poster presentation - 1st Place in the Quality, Health and Services Category of Singapore Health and Biomedical Congress 2010. Papanicolaou Smear: Knowledge, Perceptions and Practices of a Local Community of Women.   
       

Letters of Commendation & Appreciation

  • From Singapore General Hospital Chief Executive Officer – for excellent service rendered. 15.6.16
  • From National Heart Centre Singapore Medical Director – for undergraduate medical and nursing education. 18.3.21

Research Interests

  • Lung cancer screening
  • Artificial Intelligence
  • Machine learning
  • Lung cancer biomarkers
  • Video assisted thoracoscopic surgery
  • Surgical devices

Publications and Research Trials

Original Articles

  • Long-term Prognosis in Patients with End-Stage Renal Disease after Coronary Artery Bypass Grafting
    Philip Y. K. Pang, Christopher K. J. Teow, Ming Jie Huang, Madhava J. Naik, See Lim Lim, Victor T. T. Chao, Teing Ee Tan, Yeow Leng Chua, Yoong Kong Sin. Journal of Thoracic Disease. Nov 2020; 12(11): 6722–6730.
  • Prognostic factors for survival after Extracorporeal Membrane Oxygenation for cardiogenic shock.
    Huang, Mingjie; Ong, Boon Hean; Hoo, Anne Ean Ean; Gao, Fei; Chao, Victor Tar Toong; Lim, Chong Hee; Tan, Teing Ee; Sin, Kenny Yoong Kong. American Society for Artificial Internal Organs Journal. Feb 2020;66(2):141-145.
  • Restrictive Mitral Valve Annuloplasty For Chronic Ischaemic Mitral Regurgitation: Long-term Outcomes of Flexible Versus Semi-rigid Rings. Philip Y K Pang, Ming Jie Huang, Teing Ee Tan, See Lim Lim, Madhava J Naik, Victor T T Chao, Yoong Kong Sin, Chong Hee Lim, Yeow Leng Chua. Journal of Thoracic Disease. Dec 2019;11(12):5096-5106.
  • Therapeutic Hypothermia May Improve Neurological Outcomes in Extracorporeal Life Support for Adult Cardiac Arrest. Philip Y.K. Pang, MD, Gillian H.L. Wee, MN, Ming Jie Huang, MD, Anne E.E. Hoo, BSc, Ismail Mohamed Tahir Sheriff, BSc, See Lim Lim, MD, Teing Ee Tan, MD, Yee Jim Loh, MD, Victor T.T. Chao, MD, Jia Lin Soon, MD, Ka Lee Kerk, BSc, Zakir Hussain Abdul Salam, MD, MPH, Yoong Kong Sin, MD, Chong Hee Lim, MD. Heart, Lung and Circulation. January 2017; 26(8):817-824.

Abstracts

  • Tricuspid Annuloplasty using the MC3 Ring for Functional Tricuspid Regurgitation: An Analysis of Midterm Outcomes. Philip Pang, Chua Yeow Leng, Huang Mingjie, Noah Tapaua. Cardiology: International Journal of Cardiovascular Medicine, Surgery, Pathology and Pharmacology. May 2014; 128(2):159-159

Newsletters

Research Trials

  • TRICS IV: Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery. Co-investigator. 2021 – ongoing.
  • Lung Cancer Consortium Singapore National Lung Cancer Research Study. May 2022 – ongoing